HPSE and neoplasm: Due to the dual action of heparanase, the inhibition of this enzyme, when administered concomitantly with radiation therapy, is expected to exert not only direct anti-tumor effects [8] but also to protect against kidney damage induced by radiation—the backbone of cancer therapy across a broad range of abdominal/pelvic malignancies.